UPK2
UPK2 (uroplakin 2, also known as UP2 and UPII) is a component of the asymmetric unit membrane, a specialised biomembrane made by terminally differentiated urothelial cells. It may help regulate how this membrane is assembled. Browse Assay Genie's current range of UPK2 research reagents below, or read on for the biology behind the target.
UPK2 is a component of the asymmetric unit membrane (AUM), a highly specialised biomembrane elaborated by terminally differentiated urothelial cells. The protein may play an important role in regulating the assembly of the AUM. It is localised to the cell membrane, where it contributes to the apical surface of the urothelium.
The UPK2 gene encodes one of the highly conserved, urothelium-specific integral membrane proteins of the AUM, which forms the urothelium apical plaques in mammals. The UPK2 protein belongs to the uroplakin-2 family. A mouse ortholog, Upk2, is recognised, which is relevant for researchers who work with rodent models of urothelial biology. The protein is also known by the aliases UP2 and UPII.
The AUM is believed to strengthen the urothelium by preventing cell rupture during bladder distention. This gives UPK2 a clear place in studies of urothelial barrier structure and function. The encoded protein has also been found in the peripheral blood of bladder cancer patients with transitional cell carcinomas, so the UPK2 gene and its product are of interest in bladder cancer research. UPK3A is another uroplakin that is often studied alongside it.
UPK2 is a component of the asymmetric unit membrane made by terminally differentiated urothelial cells, making it a useful marker for urothelial differentiation.
UPK2 may regulate assembly of the asymmetric unit membrane, so it is relevant to work on how urothelial apical plaques form.
The asymmetric unit membrane is believed to strengthen the urothelium and prevent cell rupture during bladder distention.
UPK2 is expressed in the peripheral blood of bladder cancer patients with transitional cell carcinomas, linking it to cancer biomarker studies.
UPK2 is a component of the asymmetric unit membrane, a specialised biomembrane made by terminally differentiated urothelial cells. It may help regulate assembly of this membrane, which is believed to strengthen the urothelium and prevent cell rupture during bladder distention.
The HGNC name is uroplakin 2, and UniProt lists the protein as Uroplakin-2. Aliases include UP2, UPII and MGC138598. It belongs to the uroplakin-2 family, and the gene is found at 11q23.3 in humans.
NCBI describes the uroplakin proteins of the asymmetric unit membrane as highly conserved in mammals, and a mouse ortholog, Upk2, exists. UPK2 is expressed in the peripheral blood of bladder cancer patients with transitional cell carcinomas. Check the datasheet of any product for its validated reactivity.
Other uroplakins and urothelial membrane proteins studied alongside UPK2 in bladder research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O00526; product specifications from Assay Genie datasheets.